NEWS

Picture2_edited.png

2021 - 2022

Israel Innovation Authority 

Bio-convergence grant award

The research funds were awarded for the period of 2021-22. Project: Development of Novel Neurotropic Drug for Polyneuropathy.

רשות החדשנות

Israel Innovation Authority

%D7%A8%D7%A9%D7%95%D7%AA%20%D7%9C%D7%97%
toxins-09-00326-g001_edited.jpg

2017 - 2018

"Nofar" Ministry of Science and Industry grant awarded

The research funds were awarded for the period of 2017-18. Project: Novel Synthetic Scaffold DT100 Promotes Silencing of the Pain Receptor TRPV1.

Ministry of Economy and Industry

ITC-Logo-Sydney-Australia-with-MoE_edite
Marijuana-Plant.jpg

2019 - 2020

Contract signed with Scopus Biopharma (about Scopus)  

The Scopus Biopharma company  funded the conduct of a feasibility study for the development of protocols for synthesis of new CBD derivatives.

Multidisciplinary Center for Cannabinoid Research 

1_new.png
active%20receptor_edited.jpg

2018-2022

Israel Science Foundation (ISF) grant award

The research funds were awarded for the period of 2018-2022. Project: Stretching the Model of TRPV1 Activation.

 Israel Science Foundation (ISF)

download-1.png